R&D Systems Inc. Tocris Bioscience Boston Biochem

m-3M3FBS

Cat. No. 1941

m-3M3FBS C16H16F3NO2S [200933-14-8]

Price and Availability

For m-3M3FBS pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 2,4,6-Trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide

Biological Activity

Activator of phospholipase C (PLC). Stimulates superoxide generation, Ca2+ release and inositol phosphate formation in a variety of cell types. Also inhibits growth of the leukemic cell lines U937 and THP-1. Inactive control o-3M3FBS (Cat. No. 1942) available.

Technical Data

M.Wt:
343.36
Formula:
C16H16F3NO2S
Solubility:
Soluble to 100 mM in ethanol and to 100 mM in DMSO
Purity:
>99 %
Storage:
Store at RT
CAS No:
200933-14-8

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Bae et al (2003) Identification of a compound that directly stimulates phospholipase C activity. Mol.Pharmacol. 63 1043. PMID: 12695532.

Krjukova et al (2004) Phospholipase C activator m-3M3FBS affects Ca2+ homeostasis independently of phospholipase C activation. Br.J.Pharmacol. 143 3. PMID: 15302681.

Lee et al (2005) The novel phospholipase C activator, m-3M3FBS, induces monocytic leukemia cell apoptosis. Cancer Lett. 222 227. PMID: 15863272.

If you know of a relevant citation for this product please let us know.

Keywords: m-3M3FBS, supplier, Phospholipases, C, activators, activates, PLC, esterases

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

New Therapies and Challenges in Asthma

Written by Peter J. Barnes

Asthma Poster

'New Therapies, Challenges, and Breakthroughs in Asthma' highlights key pathways and new therapies used to treat asthma, including those currently in clinical development.

divider line

New Product Guide

NPG

Highlights over 130 new products added in the second half of 2013. Request a copy or view PDF today.

divider line

New Products in this Area

KML 29

Highly selective and potent monoacylglycerol lipase (MAGL) inhibitor

PF 8380

Potent autotaxin inhibitor

APY 29

Inhibits IRE1α autophosphorylation; activates IRE1α endoribonuclease activity

JW 642

Monoacylglycerol (MAGL) inhibitor

ML 298 hydrochloride

Selective PLD2 inhibitor

Sign-up for new product e-alerts
divider line

Tocris Events

Win $1,000 Product Credit

Experimental Biology

Experimental Biology

April 26 - 30, 2014

San Diego CA, USA

Booth Number: 918